Analyst Ranking
Bottom 11%
#3969 out of 4417 analysts
Average Return
Win Rate
40%18 out of 45
Risk vs Reward

Jacob Johnson's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Maxcyte IncMXCT
2023-10-05 -
Strong Buy
Neogenomics IncNEO
2020-04-21 -
Strong Buy
Lifecore Biomedical IncLFCR
2023-03-17 -
Strong Buy
Azenta IncAZTA
2020-11-11 -
Strong Buy
Biolife Solutions IncBLFS
2022-05-10 -
Strong Buy

Jacob Johnson Analyst Color

Get additional color on Jacob Johnson's coverage of popular stocks

Jacob Johnson's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Azenta IncAZTA
21 days ago
West Pharmaceutical Services IncWST
8Strong Buy$390.00+10.86%Maintains
a month ago
Maxcyte IncMXCT
3Strong Buy$12.00+140.96%Reiterates
2 months ago
Stevanato Group SpaSTVN
1Strong Buy$33.00+20.39%Initiates Coverage On
2 months ago
908 Devices IncMASS
2Strong Buy$14.00+81.82%Reiterates
2 months ago
3Strong Buy$250.00+22.84%Reiterates
2 months ago
Lifecore Biomedical IncLFCR
3 months ago
Neogenomics IncNEO
3Strong Buy$18.00-5.26%Upgrades
3 months ago
Societal Cdmo IncSCTL
2Strong Buy$2.50+584.93%Reiterates
4 months ago
Bio Techne CorpTECH
7Strong Buy$100.00+54.87%Reiterates
4 months ago
Repligen CorpRGEN
3Strong Buy$200.00+21.26%Maintains
4 months ago
Codexis IncCDXS
2Strong Buy$6.00+142.91%Reiterates
4 months ago
Biolife Solutions IncBLFS
3Strong Buy$29.00+118.87%Maintains
5 months ago
Cryoport IncCYRX
5 months ago
Catalent IncCTLT
1Strong Buy$50.00+24.53%Reiterates
5 months ago
Avid Bioservices IncCDMO
3Strong Buy$22.00+340.44%Reiterates
9 months ago
Alpha Teknova IncTKNO
3Strong Buy$15.00N/AMaintains
a year ago
Ligand Pharmaceuticals IncLGND
1Strong Buy$130.00N/AMaintains
2 years ago
Charles River Laboratories International IncCRL
1Strong Buy$377.00N/AInitiates Coverage On
2 years ago
Cerus CorpCERS
1Strong Buy$6.50N/AMaintains
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.